{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/parvovirus-b19-infection/management/children-adults-not-pregnant/","result":{"pageContext":{"chapter":{"id":"73c2e9d4-b567-504f-9b28-36966a247590","slug":"children-adults-not-pregnant","fullItemName":"Scenario: Children and adults (not pregnant)","depth":2,"htmlHeader":"<!-- begin field 5a178e10-968c-4fa2-8872-10927993a3a3 --><h2>Scenario: Children and adults (not pregnant)</h2><!-- end field 5a178e10-968c-4fa2-8872-10927993a3a3 -->","summary":"Covers the management of children and adults who are not pregnant, with suspected parvovirus B19 infection, or those who have been in contact with a person with suspected or confirmed parvovirus B19 infection.","htmlStringContent":"<!-- begin item 0a538c2f-cf58-4837-82c3-0efc965765d3 --><!-- begin field c1dc0c86-e170-4466-abfe-acbd00852f92 --><p>From birth to 12 years.</p><!-- end field c1dc0c86-e170-4466-abfe-acbd00852f92 --><!-- end item 0a538c2f-cf58-4837-82c3-0efc965765d3 -->","topic":{"id":"a0e6adce-f85f-55b0-8d7f-3b5e75836d40","topicId":"3ea4cf87-3eee-4e3f-a6d0-b0ee3a4ee3ad","topicName":"Parvovirus B19 infection","slug":"parvovirus-b19-infection","lastRevised":"Last revised in February 2017","chapters":[{"id":"c45face5-dc30-586a-b7ca-3b24305bd068","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"cc09231e-bb7a-5379-aeec-7c830288098e","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"2971cfc1-4839-5be6-b726-20b9383ae294","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"020d2cdb-0f7f-5bc0-a249-98fc3690b68c","slug":"changes","fullItemName":"Changes"},{"id":"af1bc49c-d614-521b-b6f3-ad084fc2aed9","slug":"update","fullItemName":"Update"}]},{"id":"7c9f0c10-cf1d-5723-856f-e0bc2d270210","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"bb1635ce-433b-5f39-a93a-27b4488878c5","slug":"goals","fullItemName":"Goals"},{"id":"3c7eed51-287a-5bcb-8519-40ef7f5784aa","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"291f85a1-8911-59d4-82d6-62ce4daff1c0","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"e66b8854-eb00-59b9-85d9-f50343f36470","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"ce817770-4fbe-5b47-b4ed-56b723012488","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"faa5c5db-5837-5cbd-8e56-78bc7ac42137","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"0f0e8f26-e2c7-5de3-b012-e340b25ad622","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"afcf1b63-41ac-5295-91b5-4e19bc828249","slug":"definition","fullItemName":"Definition"},{"id":"60a93741-3863-58bb-8394-a33804062373","slug":"prevalence","fullItemName":"Prevalence"},{"id":"1cfa61b6-71af-5e94-9e40-95b29e9f97dc","slug":"complications","fullItemName":"Complications"},{"id":"034c66fb-a99f-5a21-a031-d557dc647301","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"53019719-ec11-57d5-afd3-3ed2e9939168","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"e7eca192-b219-5e71-8ecd-6d2e6cf0f3da","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"2b824d0f-b0b0-5801-8def-a38d172c2532","slug":"investigations","fullItemName":"Investigations"},{"id":"7daba43a-1410-5703-8a94-b6530a5dfccc","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"b0275eae-f19c-57fb-834c-03df7c6dcea3","fullItemName":"Management","slug":"management","subChapters":[{"id":"73c2e9d4-b567-504f-9b28-36966a247590","slug":"children-adults-not-pregnant","fullItemName":"Scenario: Children and adults (not pregnant)"},{"id":"25b4fecb-ae9d-58f7-ad14-7ace595c0800","slug":"pregnant-women","fullItemName":"Scenario: Pregnant women"}]},{"id":"bdf3d270-5563-5eb4-804f-68fce2e7e7dd","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"73875656-8429-5584-82e6-d06c0a5f52ea","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"8dc117ba-c373-5ee0-a7aa-fc63a62a7067","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"24bd5691-28ce-53b1-be8b-f0e51e40db4b","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"6b35b969-66a8-5431-900a-a524f0bf1a89","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"63ad51a8-8325-52f2-a254-ed3ccae9f508","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"174a35a7-6fa3-58ef-9e06-6325d5f0111b","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"c6c0fc6f-31f8-5681-bbce-4ed5b6b16e4e","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"b0275eae-f19c-57fb-834c-03df7c6dcea3","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"ad750d05-a0ad-5a77-a06f-3b32b45e30af","slug":"management-of-suspected-infection","fullItemName":"Management of suspected infection","depth":3,"htmlHeader":"<!-- begin field 2f106bde-d7fb-483a-ad92-5b1e35051bc1 --><h3>How should I manage a person (not pregnant) with suspected parvovirus B19 infection?</h3><!-- end field 2f106bde-d7fb-483a-ad92-5b1e35051bc1 -->","summary":null,"htmlStringContent":"<!-- begin item 04c7bded-23da-49ca-b357-b11a46150cec --><!-- begin field 3f13ebab-62b2-46fd-a78a-1af1a30f7339 --><p><strong>For children and adults (who are not pregnant) with suspected parvovirus B19 infection:</strong></p><ul><li><strong>Assess the person's:</strong><ul><li>Date of onset, <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/diagnosis/diagnosis/\">clinical features</a>, and type and distribution of any rash and associated illness.</li><li>Previous relevant history of infection, antibody testing, and vaccine administration (with dates/places).</li><li>Known <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/management/children-adults-not-pregnant/#management-of-possible-exposure\">contact</a> with any person with a potentially infectious rash or illness (with dates of contact).</li></ul></li><li><strong>Give advice on sources of information and support,</strong> such as the NHS patient information leaflet <a data-hyperlink-id=\"2943df83-532a-40ba-9837-a98c0131c73a\" href=\"https://www.nhs.uk/conditions/slapped-cheek-syndrome/\" target=\"_blank\">Slapped cheek syndrome</a>.<ul><li>Advise the person or carer on the <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/background-information/prognosis/\">natural history</a> of parvovirus B19 infection, and reassure that it is usually a mild, self-limiting illness.</li></ul></li><li><strong>Give advice on self-management strategies for symptom relief,</strong> including:<ul><li>Getting rest and drinking adequate fluids.</li><li>Using simple analgesia, such as paracetamol or a nonsteroidal anti-inflammatory drug such as ibuprofen, if needed and appropriate. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/analgesia-mild-to-moderate-pain/\">Analgesia - mild-to-moderate pain</a> and <a class=\"topic-reference external-reference\" href=\"/topics/nsaids-prescribing-issues/\">NSAIDs - prescribing issues</a> for more prescribing information.</li></ul></li><li><strong>For healthy children who have the typical <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/diagnosis/diagnosis/\">rash</a> of slapped cheek syndrome,</strong> advise that:<ul><li>The child should no longer be infectious once the rash develops, and it is<em> </em>not<em> </em>necessary for the child to stay off school or nursery. See the Public Health England (PHE) document <a data-hyperlink-id=\"b4213c72-f0b3-41fb-895e-a98c0131c7a3\" href=\"https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/522337/Guidance_on_infection_control_in_schools.pdf\" target=\"_blank\">Guidance on infection control in schools and other childcare settings</a> for more information.</li><li>It is not necessary to avoid contact with pregnant women.</li><li>School or nursery should be informed of the child's suspected parvovirus B19 infection, so that the following groups of people can be managed effectively:<ul><li>People at risk of <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/background-information/complications/\">complications</a> (such as pregnant women, and children and adults who are immunocompromised or have a haematological disorder) who have been in contact with the child during the prodromal period. See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/management/children-adults-not-pregnant/#management-of-possible-exposure\">How should I manage a person (not pregnant) with possible exposure to parvovirus B19 infection?</a> for more information.</li><li>Other nursery or school children who develop possible <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/diagnosis/diagnosis/\">prodromal symptoms</a>.</li></ul></li></ul></li><li><strong>For healthy adults with suspected parvovirus B19 infection:</strong><ul><li>Advise that it is not usually necessary to stay off work if symptoms are controlled.</li><li>Check the person's rubella status if they have not been fully immunized against rubella or got a documented history of previous rubella infection. It may be sensible to avoid contact with pregnant women while any rash is present, until the person's rubella status is known.</li></ul></li><li><strong>For people who are at risk of <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/background-information/complications/\">complications</a>,</strong> ensure that appropriate <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/diagnosis/investigations/\">laboratory&nbsp;investigations</a> have been arranged to:<ul><li>Confirm the diagnosis of parvovirus B19 infection.</li><li>Check the full blood count (including reticulocyte count).</li></ul></li><li><strong>Arrange follow up in primary care, referral, or admission, if appropriate.</strong><ul><li>Consider arranging an urgent full blood count including reticulocyte count (if not already done) or emergency admission for people with symptoms of <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/background-information/complications/\">severe or aplastic anaemia</a> (such as breathlessness, lightheadedness, lethargy, or confusion), depending on clinical judgement.<ul><li>If there is any uncertainty about appropriate management of anaemia and/or a low reticulocyte count, seek urgent specialist advice from a haematologist.</li></ul></li><li>If a person at risk of complications has a confirmed diagnosis of parvovirus B19 infection, seek specialist advice from the local virology, microbiology, or infectious diseases department on further testing and follow up.</li><li>If an adult has severe or persistent symptoms of <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/diagnosis/diagnosis/\">arthropathy</a>, consider whether <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/diagnosis/investigations/\">laboratory investigations</a> or referral to a rheumatologist is needed to confirm the diagnosis and exclude <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/diagnosis/differential-diagnosis/\">other causes</a>. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/rheumatoid-arthritis/\">Rheumatoid arthritis</a> for more information.</li></ul></li><li><strong>Contact the local virology, microbiology, or infectious diseases department for further advice</strong> if there is any uncertainty about the need for laboratory monitoring or isolation of the person.</li></ul><!-- end field 3f13ebab-62b2-46fd-a78a-1af1a30f7339 --><!-- end item 04c7bded-23da-49ca-b357-b11a46150cec -->","subChapters":[{"id":"09928347-4507-5543-a343-70368151a4fe","slug":"basis-for-recommendation-0f9","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 8fe3d877-9ef0-4727-b117-fa55b742acd0 --><h4>Basis for recommendation</h4><!-- end field 8fe3d877-9ef0-4727-b117-fa55b742acd0 -->","summary":null,"htmlStringContent":"<!-- begin item 0f93c342-74e5-41f5-8edb-615dd8745448 --><!-- begin field 2b07973a-87ed-4eba-b5b6-02d7a6ca32e3 --><h5>Assessment of the person</h5><ul><li>The recommendations on how to assess a person with suspected parvovirus B19 infection are extrapolated from expert opinion in the Public Health England (PHE) publication <em>Guidance on viral rash in pregnancy</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">HPA, 2011</a>] and expert opinion in a review article on common skin conditions in children [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">Allmon, 2015</a>].</li></ul><h5>Advice on self-management strategies</h5><ul><li>The recommendations on self-management strategies for symptom relief are based on expert opinion in a review article on parvovirus B19 infection and roseola infantum [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">O&#39;Grady, 2014</a>] and a review article on common skin conditions in childhood [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">Allmon, 2015</a>].</li></ul><h5>Advice on exclusion from school, nursery, or work and isolation from at-risk contacts</h5><ul><li>The recommendations on not needing to stay off school, nursery, or work are based on or extrapolated from expert opinion in the PHE publication <em>Guidance on infection control in schools and other childcare settings</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">PHE, 2016</a>].<ul><li>In children with a typical rash, there is no need for exclusion from school or nursery, as by the time the rash has developed, the period of infectivity has passed.</li><li>The recommendation on informing the school or nursery about the suspected infection ensures that other children can be managed appropriately if they develop prodromal symptoms (which is when parvovirus B19 infection is most infectious). In addition, immunocompromised people are at increased risk of serious or life-threatening complications if they are infected with parvovirus B19, and these people may not present with typical symptoms.</li></ul></li><li>The recommendation for people with uncertain rubella immunization status to avoid contact with pregnant women is pragmatic, as it is difficult to clinically differentiate between parvovirus B19 and rubella infection, and both may have serious or life-threatening sequelae for the fetus (or more rarely, the mother).</li></ul><h5>Arranging laboratory investigations for people at risk of complications</h5><ul><li>These recommendations are based on expert opinion in a review article on human parvovirus B19 [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">American Association of Blood Banks, 2009</a>] and a review article on parvovirus B19 infection and people with sickle cell disease and thalassaemia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">Slavov, 2011</a>].<ul><li>Parvovirus B19 attacks erythroid progenitor cells, and can exacerbate or provoke severe anaemia in some people who have a haematological disorder.</li></ul></li></ul><h5>Arranging follow up, admission, or referral</h5><ul><li>The recommendation on checking an urgent full blood count (including reticulocyte count) if severe or aplastic anaemia is suspected is extrapolated from expert opinion in a review article on parvovirus B19 infection and people with sickle cell disease and thalassaemia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">Slavov, 2011</a>].<ul><li>Rarely, parvovirus B19 may cause anaemia in healthy people, or parvovirus B19-induced anaemia may be the first indication of an underlying haematological disorder.</li></ul></li><li>The recommendation on seeking specialist advice from a haematologist if there is any uncertainty about management if anaemia or reticulocytosis is confirmed, is pragmatic based on what CKS considers to be good clinical practice.</li><li>The recommendation on seeking specialist advice if a person at increased risk of complications has confirmed parvovirus B19 infection is pragmatic and has been extrapolated from expert opinion in a review article on human parvovirus B19 [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">American Association of Blood Banks, 2009</a>] and a review article on parvovirus B19 infection and people with sickle cell disease and thalassaemia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">Slavov, 2011</a>].<ul><li>People with haematological disorders are at increased risk of transient aplastic crisis (especially those with a reticulocytopenia), which can be life-threatening if left untreated [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">American Association of Blood Banks, 2009</a>].</li><li>People who are immunocompromised are at increased risk of persistent parvovirus B19 infection, leading to chronic, severe anaemia (pure red cell aplasia) which may require intravenous immunoglobulin G (IVIG) treatment in secondary care. This group of people may not produce a normal antibody response to infection, and may not exhibit typical symptoms, but may present with severe anaemia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">Slavov, 2011</a>].</li></ul></li><li>The recommendation on arranging specialist referral to confirm the diagnosis in people with persistent or severe arthropathy is based on expert opinion in a review article on parvovirus B19 infection and roseola infantum [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">O&#39;Grady, 2014</a>].</li></ul><h5>Seeking specialist advice</h5><ul><li>The recommendation on seeking advice from the local virology, microbiology, or infectious diseases department if there is uncertainty about ongoing management is extrapolated from expert opinion in a review article on pregnant women exposed to childhood rash [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">MacMahon, 2012</a>].</li></ul><!-- end field 2b07973a-87ed-4eba-b5b6-02d7a6ca32e3 --><!-- end item 0f93c342-74e5-41f5-8edb-615dd8745448 -->","subChapters":[]}]},{"id":"4487b488-0ac8-519a-8a08-e8bc636302a4","slug":"management-of-possible-exposure","fullItemName":"Management of possible exposure","depth":3,"htmlHeader":"<!-- begin field 60215b02-038e-4989-962e-639f7cb0b845 --><h3>How should I manage a person (not pregnant) with possible exposure to parvovirus B19 infection?</h3><!-- end field 60215b02-038e-4989-962e-639f7cb0b845 -->","summary":null,"htmlStringContent":"<!-- begin item 0f1f3efd-5030-4018-9488-787ff09484c6 --><!-- begin field d5f1fee2-86a4-4046-b86b-a7cb56a0e5b8 --><p><strong>For children and adults (who are not pregnant) who have had possible exposure to parvovirus B19 infection:</strong></p><ul><li><strong>Assess whether, and when, there has been significant contact with any person with a potentially infectious rash or illness (before the onset of rash, if any).</strong><ul><li>Significant contact is defined as being in the same room for 15 minutes or more, or face-to-face contact with the person, within the previous 3 weeks.</li><li>Be aware that the greatest risk comes from any children in the person's household, rather than the workplace.</li></ul></li><li><strong>If the person has had possible exposure, advise on measures to reduce the risk of transmission</strong> to people at risk of <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/background-information/complications/\">complications</a>:<ul><li>The person should avoid contact with pregnant women, and children or adults who are immunocompromised or have a haematological disorder, until they are no longer potentially infectious.<ul><li>The infectious period is 7–10 days before the rash (if any) develops, until one day after the rash appears.</li><li>If there is any uncertainty on the requirements for isolation from at-risk people, contact the local virology, microbiology, or infectious diseases department for further specialist advice.</li></ul></li><li>The parent or carer should inform school or nursery. See the Public Health England (PHE) document <a href=\"https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/522337/Guidance_on_infection_control_in_schools.pdf\" target=\"_blank\" data-hyperlink-id=\"5872ad28-662f-4e1e-a34d-a991005a185a\">Guidance on infection control in schools and other childcare settings</a> for more information.</li></ul></li><li><strong>If the person develops symptoms of active infection or suspected <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/background-information/complications/\">severe or aplastic anaemia</a>,</strong> see the section on <a class=\"topic-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/management/children-adults-not-pregnant/#management-of-suspected-infection\">How should I manage a person (not pregnant) with suspected parvovirus B19 infection?</a> for more information on management.</li></ul><!-- end field d5f1fee2-86a4-4046-b86b-a7cb56a0e5b8 --><!-- end item 0f1f3efd-5030-4018-9488-787ff09484c6 -->","subChapters":[{"id":"bf36e6ec-5fdc-5d1d-97a0-00a6952ea3d2","slug":"basis-for-recommendation-995","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field f16b7701-3dd9-4681-9077-a9c867cea87e --><h4>Basis for recommendation</h4><!-- end field f16b7701-3dd9-4681-9077-a9c867cea87e -->","summary":null,"htmlStringContent":"<!-- begin item 995ef2a1-9a59-4062-928f-84b04e5ac63f --><!-- begin field 17fcdc64-4f27-4971-a3b2-2c88b1d61c81 --><h5>Definition of significant contact</h5><ul><li>The information on what constitutes significant contact is extrapolated from expert opinion in the Public Health England (PHE) publication <em>Guidance on viral rash in pregnancy</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">HPA, 2011</a>].<ul><li>The definition is based on research on varicella (chickenpox) transmission. As varicella is significantly more infectious than parvovirus B19, this is likely to be a conservative definition. Determining contact with parvovirus B19 may be difficult, because exposure to the virus occurs before the development of rash or other symptoms, and about 20% of children and up to 50% of adults are asymptomatic.</li></ul></li><li>The information that the greatest risk of transmission is from an infected child who is a close household contact is based on expert opinion in the PHE publication <em>Guidance on infection control in schools and other childcare settings</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">PHE, 2016</a>].</li></ul><h5>Advice on measures to reduce the risk of transmission</h5><ul><li>The recommendation on avoiding contact with at-risk groups is based on the fact that these people are at increased risk of developing serious or life-threatening complications from parvovirus B19 infection, and they may not present with typical symptoms [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">Slavov, 2011</a>].</li><li>The information on the infectious period is based on expert opinion in the PHE publication <em>UK Standards for microbiology investigations. Investigation of pregnant women exposed to non-vesicular rash</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">PHE, 2015</a>] and in a review article on pregnant women exposed to childhood rash [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">MacMahon, 2012</a>].</li><li>The recommendation on seeking specialist advice if there is uncertainty regarding ongoing management is extrapolated from expert opinion in a review article on pregnant women exposed to childhood rash [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">MacMahon, 2012</a>].</li><li>The recommendation on informing the school or nursery about the possible exposure is based on expert opinion in the PHE publication <em>Guidance on infection control in schools and other childcare settings</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/parvovirus-b19-infection/references/\">PHE, 2016</a>].<ul><li>This ensures that other children can be managed appropriately if they develop prodromal symptoms (which is when parvovirus B19 infection is most infectious).</li></ul></li></ul><!-- end field 17fcdc64-4f27-4971-a3b2-2c88b1d61c81 --><!-- end item 995ef2a1-9a59-4062-928f-84b04e5ac63f -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}